Penumbra, Inc. Introduces REAL® i-Series™, Expanding Real Immersive System to Support Broad Range of Care Providers and Mental Health Professionals
August 10, 2021 at 09:00 am EDT
Share
Penumbra, Inc. announced the introduction of the REAL® Immersive System i-Series™, offering engaging, immersive, gaze-based experiences and activities to care providers and mental health professionals. The REAL i-Series features a virtual reality-enabled headset with intuitive gaze navigation and exclusive experiences and activities, including REAL Connect™, a first-to-market advanced capability, providing one-to-one real-time video and audio communication. REAL i-Series is designed for a broad range of care providers and mental health professionals. Often these healthcare providers seek tools to aid cognition and mental well-being as they support people with depressed and anxious moods, pain and discomfort, loneliness and age-related challenges. These providers deliver care across a wide-range of settings, including hospitals, clinics and senior-living communities. REAL i-Series features experiences and activities designed to address mental well-being and cognition, including animated, interactive experiences via the Serene Lake™ application and 360-degree video instructor-guided and self-guided travel and nature experiences. Together, these experiences feature over 10 hours of immersive content aimed at offering VR-enabled tools for cognitive activation, distraction therapy, reminiscence therapy, mindfulness practice and relaxation. The REAL i-Series also includes REAL Connect, a first-to-market advanced capability, providing one-to-one real-time video and audio communication. REAL Connect is designed to enhance the immersive experience through social connection by allowing users to share their VR-based activities with another individual through a web-based portal. REAL i-Series follows the recent commercialization of the REAL Immersive System, which is designed for clinicians to address the individual needs of high-acuity to high-functioning patients in a rehabilitation setting. Its activities address upper extremity impairments, core and balance, cognition, functional uses, activities of daily living training, distraction and low stimulation environments.
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.